[go: up one dir, main page]

MX2016008118A - Composiciones de isoxazolina y uso de las mismas en la prevencion o tratamiento de infestaciones parasitarias en animales. - Google Patents

Composiciones de isoxazolina y uso de las mismas en la prevencion o tratamiento de infestaciones parasitarias en animales.

Info

Publication number
MX2016008118A
MX2016008118A MX2016008118A MX2016008118A MX2016008118A MX 2016008118 A MX2016008118 A MX 2016008118A MX 2016008118 A MX2016008118 A MX 2016008118A MX 2016008118 A MX2016008118 A MX 2016008118A MX 2016008118 A MX2016008118 A MX 2016008118A
Authority
MX
Mexico
Prior art keywords
animals
infestations
parasitary
isoxazoline
prevention
Prior art date
Application number
MX2016008118A
Other languages
English (en)
Other versions
MX373872B (es
Inventor
Annie Flochlay-Sigognault
LEHAY Anne
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2016008118A publication Critical patent/MX2016008118A/es
Publication of MX373872B publication Critical patent/MX373872B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invención está dirigida a una composición farmacéutica para administración con agua potable, que comprende compuestos de isoxazolina de la Fórmula (I) y un surfactante de polisorbato y éter monoetílico de dietilenglicol (transcutol); y el uso de la composición para tratar o prevenir infestaciones parasitarias de animales.
MX2016008118A 2013-12-20 2014-12-19 Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales. MX373872B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199006 2013-12-20
PCT/EP2014/078634 WO2015091898A1 (en) 2013-12-20 2014-12-19 Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals

Publications (2)

Publication Number Publication Date
MX2016008118A true MX2016008118A (es) 2016-09-16
MX373872B MX373872B (es) 2020-03-26

Family

ID=49880542

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008118A MX373872B (es) 2013-12-20 2014-12-19 Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales.

Country Status (11)

Country Link
US (4) US10456358B2 (es)
EP (2) EP4306168B1 (es)
JP (1) JP6581586B2 (es)
CN (2) CN105813651B (es)
ES (2) ES2971061T3 (es)
HU (2) HUE066811T2 (es)
MX (1) MX373872B (es)
PL (2) PL3082867T3 (es)
PT (1) PT4306168T (es)
RU (1) RU2688919C1 (es)
WO (1) WO2015091898A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4306168B1 (en) * 2013-12-20 2025-06-25 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
FI4008329T3 (fi) * 2014-12-22 2025-08-22 Intervet Int Bv Isoksatsoliiniyhdisteitä käytettäväksi hoidettaessa demodikoosia
EP3313400B1 (en) * 2015-06-23 2022-06-15 Intervet International B.V. Isoxazoline solution containing vitamin e for use with sanitized drinking water
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
MA46641A (fr) * 2016-10-31 2019-09-04 Scripps Research Inst Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteur
PH12020550555B1 (en) * 2017-11-07 2024-03-06 Intervet Int Bv Injectable isoxazoline pharmaceutical compositions and uses thereof
KR102694519B1 (ko) 2017-11-07 2024-08-13 인터벳 인터내셔널 비.브이. 큰 크기의 이속사졸린 입자를 제조하는 방법
CN119157876A (zh) * 2017-12-15 2024-12-20 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
AU2018390796B2 (en) * 2017-12-20 2024-07-04 Intervet International B.V. System for external fish parasite monitoring in aquaculture
AU2018387713B2 (en) 2017-12-20 2024-08-08 Intervet International B.V. System for external fish parasite monitoring in aquaculture
CN111491508B (zh) * 2017-12-20 2022-05-24 英特维特国际股份有限公司 用于水产养殖中的鱼外部寄生虫监测的系统
US12127535B2 (en) 2017-12-20 2024-10-29 Intervet Inc. Method and system for external fish parasite monitoring in aquaculture
CN111511203B (zh) 2017-12-20 2023-04-04 英特维特国际股份有限公司 用于水产养殖中的鱼外部寄生虫监测的方法和系统
KR102142916B1 (ko) * 2018-08-17 2020-08-10 부산대학교 산학협력단 상향식 방법을 통한 난용성 약물을 포함하는 나노현탁액의 제조방법 및 이로 제조된 나노현탁액
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
AU2020295570A1 (en) * 2019-06-19 2022-02-10 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
US20220249445A1 (en) * 2019-06-19 2022-08-11 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
US12497370B2 (en) 2019-12-18 2025-12-16 Elanco Tiergesundheit Ag Isoxazoline derivatives
AU2021311722A1 (en) 2020-07-24 2023-02-02 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
CN117320554A (zh) * 2021-03-11 2023-12-29 碗中动物健康公司 用于控制犬科动物中蜱侵袭的口服犬科动物饲料和方法
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN117064851A (zh) * 2023-09-20 2023-11-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727648A1 (de) 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
SI1731512T1 (sl) 2004-03-05 2015-01-30 Nissan Chemical Industries, Ltd. Z izoksazolinom substituirana benzamidna spojina in sredstvo za uravnavanje škodljivih organizmov
WO2007053902A1 (en) * 2005-11-10 2007-05-18 Bomac Animal Health Pty Limited Method of treating parasites
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) * 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
US8389738B2 (en) 2008-07-09 2013-03-05 Nissan Chemical Industries, Ltd. Production method of isoxazoline-substituted benzoic acid amide compound
WO2010003923A1 (en) * 2008-07-09 2010-01-14 Basf Se Pestcidal active mixtures comprising isoxazoline compounds i
NZ592865A (en) * 2008-11-19 2013-08-30 Merial Ltd Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
BRPI0923009B1 (pt) 2008-12-19 2018-07-17 Elanco Tiergesundheit Ag compostos de isoxazolina, composição para o controle de parasitas e uso de compostos de isoxazolina para o preparo de composição para o controle de parasitas
CN102596968B (zh) 2009-07-30 2015-05-06 梅里亚有限公司 杀虫的4-氨基-噻吩并[2,3-d]-嘧啶化合物及其使用方法
WO2011154434A2 (en) 2010-06-09 2011-12-15 Syngenta Participations Ag Pesticidal mixtures including isoxazoline derivatives
DK178277B1 (da) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
ES2908094T5 (en) 2010-12-27 2025-08-12 Intervet Int Bv Topical localized isoxazoline formulation
AU2011351579B2 (en) * 2010-12-27 2016-04-21 Intervet International B.V. Topical localized isoxazoline formulation comprising glycofurol
AU2012215440B2 (en) 2011-02-10 2015-08-27 Novartis Tiergesundheit Ag Isoxazoline derivatives for controlling invertebrate pests
EP2683723B1 (en) 2011-03-10 2016-05-25 Zoetis Services LLC Spirocyclic isoxazoline derivatives as antiparasitic agents
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
BR112014004235A2 (pt) 2011-08-25 2017-03-21 Syngenta Participations Ag derivados de isoxazolina como compostos inseticidas
CN106474120B (zh) * 2011-09-12 2020-07-28 勃林格殷格翰动物保健美国公司 包含异噁唑啉活性剂的杀寄生物组合物，其方法和用途
JP2014534182A (ja) 2011-10-03 2014-12-18 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物としてのイソオキサゾリン誘導体
CN108685894B (zh) 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
FI3052080T3 (fi) 2013-09-30 2025-08-22 Zoetis Services Llc Pitkävaikutteisia spiro-isoksatsoliiniformulaatioita
BR112016014216B1 (pt) * 2013-12-20 2022-08-30 Intervet International B.V. Usos de um composto isoxazolina
EP4306168B1 (en) * 2013-12-20 2025-06-25 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals

Also Published As

Publication number Publication date
PT4306168T (pt) 2025-07-24
EP3082867B1 (en) 2024-01-17
ES3036365T3 (en) 2025-09-18
EP3082867A1 (en) 2016-10-26
RU2688919C1 (ru) 2019-05-23
EP4306168A3 (en) 2024-03-13
PL4306168T3 (pl) 2025-11-17
CN110327468B (zh) 2023-04-28
PL3082867T3 (pl) 2024-05-13
RU2019114223A (ru) 2019-06-28
EP4306168A2 (en) 2024-01-17
MX373872B (es) 2020-03-26
CN105813651A (zh) 2016-07-27
US10456358B2 (en) 2019-10-29
EP4306168B1 (en) 2025-06-25
WO2015091898A1 (en) 2015-06-25
JP2016540809A (ja) 2016-12-28
US20200000720A1 (en) 2020-01-02
CN105813651B (zh) 2021-11-23
ES2971061T3 (es) 2024-06-03
HUE072822T2 (hu) 2025-12-28
RU2016129474A (ru) 2018-01-25
US20160317439A1 (en) 2016-11-03
US20210353537A1 (en) 2021-11-18
JP6581586B2 (ja) 2019-09-25
HUE066811T2 (hu) 2024-09-28
US20240122849A1 (en) 2024-04-18
CN110327468A (zh) 2019-10-15
US11883530B2 (en) 2024-01-30

Similar Documents

Publication Publication Date Title
MX2016008118A (es) Composiciones de isoxazolina y uso de las mismas en la prevencion o tratamiento de infestaciones parasitarias en animales.
DOP2015000274A (es) Compuestos químicos
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CL2018000318A1 (es) Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925)
CL2016001131A1 (es) Uso de una combinación farmacéutica que comprende un compuesto inhibidor de mdm2 y uno o más agentes activos adicionales para el tratamiento del cáncer y composiciones farmacéuticas que comprenden dichas combinaciones.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2015001377A1 (es) Inhbibidores de bmi-1 primidinas sustituidas inversas
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
UY36112A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CU20160149A7 (es) Compuestos de heteroarilo o arilo bicíclicos fusionados y su uso como inhibidores de irak4
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
SV2018005687A (es) Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
CL2015002635A1 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2017007829A (es) Composicion antimicrobiana.
GT201700023A (es) Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
MX2015015506A (es) Peptidos antimicrobianos.
DOP2015000170A (es) Compuestos químicos
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
BR112018007664A2 (pt) antagonistas de ep4
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.

Legal Events

Date Code Title Description
FG Grant or registration